1 / 32

報告人:張聰舜 報告日期: 2006-2-13

報告人:張聰舜 報告日期: 2006-2-13.

sibley
Télécharger la présentation

報告人:張聰舜 報告日期: 2006-2-13

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. 報告人:張聰舜 報告日期:2006-2-13

  2. A male immigrant from Mexico was seen in the dermatology clinic at a California hospital for examination of a large, painless, cutaneous ulcer on his ear. There was evidence of cartilage destruction in the area. A biopsy specimen was taken from the skin lesion and was sent to the laboratory for examination. A section stained with hematoxylin and eosin showed small, oval, nonflagellated protozoan amastigotes. A diagnosis of a blood-borne parasitic infection was made, based on the morphological appearance of the Giemsa-stained smear.

  3. Leishmania mexicana complex

  4. Classification • 原生動物界(Protista)-原生動物亞界(Protozoa)-變形鞭毛蟲門(Sarcomastigophora)-鞭毛蟲亞門(Mastigophra)-動鞭毛蟲綱(Zoomastigophorea)-動質蟲目(Kinetoplastida) • 利什曼原蟲(Leishmania) • 錐蟲(Trypanosoma)

  5. Classification • L. donovani • L. donovani donovani、L. donovani chagas、L. donovani infantum • L. tropica • L. tropica aethiopica、 L. tropica major、 L. tropica minor、 L. tropica tropica • L. maxicana • L. maxicana amazonensis、 L. maxicana mexicana、 L. maxicana pifanoi • L. viannia(L. braziliensis) • L. viannia braziliensis、L. viannia guyanensis、L. viannia panamensis、L. viannia peruviana

  6. Classification

  7. Epidemiology • North-Eastern China, India, Middle-East, Southern Europe (Mediterranean bassin), Northern Africa, Central-East Africa and, in foci, Central and South America (especially Brazil and Honduras).

  8. Epidemiology • O.W.L. is found especially in Asia (Middle East), Northern Africa and Southern Europe. • N.W.L. has a wide distribution in Central and South America (from Yucatan to Brazil). • The mucocutaneous form is prevalent in South America.

  9. Life Cycle • 無鞭毛體 amastigote (Leishman-Donovan body) • found intracellularly in the vertebrate (i.e., human) host • 前鞭毛體 promastigote (leptomonad) • found in the digestive tract of the invertebrate host

  10. Life Cycle

  11. Vector • Sandfly(白蛉):order Diptera(雙翅目)-family Phlebotomidae(白蛉科)or Psychodidae (毛蠓科 ). It includes the genera as follows: • Phlebotomus genus(白蛉屬) • Lutzomyia genus(沙蠅屬) • Psychodopygus genus

  12. Sandfly • small size, long legs, and abundant hair on both wings and body • flying, biting, blood-sucking insect • Most sandflies will bite any warm-blooded animal and one species attacks penguins. • Only female sandflies bite • New world- Lutzomyia • Old world- Phlebotomus

  13. Animal reservoirs • 人畜共通病(Zoonosis) • 齧齒目動物 ,樹懶 ,有袋動物 ,食肉動物 • 印度的VsceralLeishmaniasis 幾乎侷限於人 • L. major 在亞洲鄉村是野生齧齒;在亞洲都市是犬;在非洲市齧齒

  14. Cutaneousleishmaniasis • O.W.L. is found especially in Asia (Middle East), Northern Africa and Southern Europe. • N.W.L. has a wide distribution in Central and South America (from Yucatan to Brazil). • The mucocutaneous form is prevalent in South America.

  15. Cutaneousleishmaniasis • incubation period is 2~8 weeks • erythematous papule nodule nodule ulcerates and crusts • typically large but painless unless there is secondary bacterial or fungal infection. • Old World Cutaneous leishmaniasis • Leishmania, subgenus Leishmania, complexes major, tropica, donovani (infantum species), aethiopica (diffuse form). • dry or urban cutaneous leishmaniasis is caused by Leishmania tropica • wet or rural cutaneous leishmaniasis is caused by L. major • Ethiopian cutaneous leishmaniasis is caused by L. aethiopica • New World Cutaneous leishmaniasis • Leishmania, subgenus Leishmania, complex mexicana (mexicana, amazonensis, pifanoi)and subgenus Viannia, complexes brasiliensis and guyanensis • develop and heal similarly to those of the Old World forms but tend to be less nodular and more ulcerative and destructive • some common forms are mucocutaneous leishmaniasis

  16. Old World Cutaneous leishmaniasis • dry cutaneous • large urban areas in the Middle East, the Mediterranean region, and the Indian subcontinent • Leishmania tropica • vectors Phlebotomus sergenti and P. papatasi • reservoir may be either human or canine(犬) • A slowly developing single lesion that persists for a year or more • wet cutaneous • rural areas in parts of the Middle East, central Asia, and the Indian subcontinent • Leishmania major • reservoirs are desert rodents such as squirrels(松鼠) and gerbils (沙鼠) • vector Phlebotomus papatasi • Infection is acute, rapidly evolving, and characterized by multiple sores with inflammation, ulceration, and crusting • Ethiopian cutaneous • the highlands of Kenya and Ethiopia • Leishmania aethiopica • hyraxes(蹄兔) • vectors are Phlebotomus pedifer and P. longipes • less inflamed and more chronic • self-limited but may develop into diffuse cutaneous leishmaniasis

  17. Old World Cutaneous leishmaniasis

  18. New World Cutaneous leishmaniasis • Mucocutaneous • chronic, progressive metastatic spread of the lesions of New World cutaneous leishmaniasis • Leishmania viannia braziliensis • nasal, pharyngeal, and buccal mucosa months to years after the appearance of the initial cutaneous lesion,which has usually healed. • mutilating destruction of the nasal septum, palate, lips, pharynx, and larynx

  19. Diffuse cutaneous leishmaniasis • rare chronic form • Leishmania aethiopica in Ethiopia and Kenya • L. pifanoi in Venezuela • L. viannia in South America • L. mexicana complexes in Central America • local and hematogenous spread from a primary lesion to produce generalized nodular lesions resembling those of lepromatous leprosy in the skin and sometimes involving the nasal mucosa and laryngopharynx.

  20. Diagnosis • a history of exposure to sandfies • Risk factors for HIV should besolicited, including sexual encounters, intravenousdrug use, and blood transfusions obtained abroad. • symptoms • isolation of the organisms from the lesion aspirate or biopsy, by direct examination or culture • A skin test (delayed hypersensitivity: Montenegro test) and detection of anti-leishmanial antibodies by immuno-fluorescence are indicative of exposure.

  21. Diagnosis

  22. Diagnosis • Cutaneous scraping • the simplest and most common test • only 70 to 75 percent sensitive • fixed with methanol, stained with Giemsa, and examined under oil immersion. • Amastigotes are seen in monocytes or extracellularly • It is important to see the nucleus and the rod-shaped kinetoplast, a mitochondrial structure containing extranuclear DNA, to diagnose leishmaniasis.

  23. Treatment • Sodium stibogluconate is the drug of choice. • Machanism unknown • Side effect(reversible) • Gastrointestinal symptoms • Fever • Headache • Myalgia , arthralgia • Rash • ECG changes, ex. T waves change and QT prolongation

  24. Treatment

  25. Quiz 1 • Which infection does this patient have? What is the name of the hemoflagellate causing his infection?

  26. Quiz 2 • Name the three main species belonging to this complex.

  27. Quiz 3 • Which vector is responsible for the transmission of this infection?

  28. Quiz 4 • Describe the life cycle of this parasite.

  29. Quiz 5 • What are the reservoirs for these parasites? Which populations are at particular risk of infection with these parasites?

  30. Quiz 6 • How is the diagnosis of this infection made?

  31. Quiz 7 • How is this infection treated?

  32. Reference • 醫用寄生蟲學 • http://www.cdfound.to.it/html/atlas.htm#atlas • http://www.biosci.ohio-state.edu/~parasite/home.html • http://en.wikipedia.org/ • http://www.dpd.cdc.gov/dpdx/Default.htm • http://pathmicro.med.sc.edu/book/welcome.htm • Basic and clinincally pharmacology

More Related